ТРОМБОЭМБОЛИЯ ЛЕГОЧНОЙ АРТЕРИИ В АКУШЕРСКОЙ ПРАКТИКЕ
https://doi.org/10.21518/2079-701X-2017-13-94-108
Аннотация
Тромбоэмболия легочной артерии представляет собой внезапную остановку кровотока в ветви легочной артерии вследствие закупорки ее тромбом или эмболом, является составной частью синдрома тромбоза системы верхней и нижней полых вен. В настоящее время эти заболевания принято рассматривать как компоненты единого патологического процесса – венозного тромбоэмболизма.
Об авторах
С. В. Акиньшина
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Россия
Россия
к.м.н.,
Москва
В. О. Бицадзе
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Россия
Москва
Россия
Москва
Список литературы
1. Goodnight SH, Hathaway WE. Disordes of haemostasis and thrombosis. Clinical guide. Seconde edition. McGraw-Hill, Inc. 2001. p. 622.
2. Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost, 2006 Oct, 32(7): 651-8.
3. De Swiet M. Maternal mortality: Confidential inquiries into maternal deaths in United Kingdom. Am. J. Obstet. Gynecol., 2000, 183: 1271.
4. Письмо о материнской смертности в Российской федерации в 2001 году № 2510/10836-02-32// 31 октября 2002 г.
5. Яковлев В.Б. Тромбоэмболия легочной артерии в многопрофильном клиническом стационаре (распространенность, диагностика, лечение, организация специализированной медицинской помощи). Дисс. … докт. мед. наук. М., 1995. 47 с.
6. Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration, 2003 Jan-Feb, 70(1): 7-30.
7. Макацария А.Д., Бицадзе В.О. Тромбофилии и противотромботическая терапия в акушерской практике. М., «Триада Х». 2003. 904 с.
8. Bergqvist D, Hedner U. Pregnancy and venous thrombo-embolism. Acta Obstet Gynecol Scand, 1983, 62(5): 449-53.
9. McColl MD, Ellison J, Greer IA, Tait RC, Walker ID. Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol, 2000 Feb, 108(2): 272-4.
10. Anderson FA Jr, Spencer FA Risk Factors for Venous Thromboembolism. Circulation, 2003, 107: 9-16.
11. Brenner B. Haemostatic changes in pregnancy. Thromb Res, 2004, 114(5-6): 409-14.
12. James AH. Thrombosis in pregnancy and maternal outcomes. Birth Defects Res C Embryo Today, 2015 Sep, 105(3): 159-66.
13. Bick RL, Frenkel EP, Backer WF, Sarode R. Hematological complications in obstetrics, pregnancy, and gynecology.UK, Cambridge University press, 2006. p 604.
14. Mardy AH, Siddiq Z, Ananth CV, Wright JD, DʼAlton ME, Friedman AM. Venous Thromboembolism Prophylaxis During Antepartum Admissions and Postpartum Readmissions. Obstet Gynecol, 2017 Aug, 130(2): 270-278.
15. Макацария А.Д., Бицадзе В.О., Акиньшина С.В. Тромбозы и тромбоэмболии в акушерско-гинекологической практике: Молекулярно-генетические механизмы и стратегия профилактики тромбоэмболических осложнений: Рук. для врачей. М.: ООО «Медицинское информационное агентство», 2007. 1064 с.
16. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica, 2002 Oct, 87(10): 1095-108.
17. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 2003, 361: 901–908.
18. Pierangeli SS, Leader B, Barilaro G, Willis R, Branch DW. Acquired and inherited thrombophilia disorders in pregnancy. Obstet Gynecol Clin North Am, 2011 Jun, 38(2): 271-95.
19. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost, 2006 Feb, 4(2): 295-306.
20. Esteve-Valverde E, Ferrer-Oliveras R, AlijotasReig J.Obstetric antiphospholipid syndrome. Rev Clin Esp, 2016 Apr, 216(3): 135-45.
21. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med, 1999 Mar 25, 340(12): 901-7.
22. Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P. Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost, 2006 Oct, 32(7): 700-8.
23. Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol, 2003 Jun, 16(2): 243-59.
24. Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, Novak-Antolic Z. Factor V Leiden, prothrombin 20210G –> A, methylenetetrahydrofolate reductase 677C –> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancyrelated venous thromboembolism. Eur J Obstet Gynecol Reprod Biol, 2003 Dec 10, 111(2): 157-63.
25. McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA.Prothrombin 20210 G –>A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG, 2000 Apr, 107(4): 565-9.
26. Biron-Andreani C, Schved JF, Daures JP.Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis. Thromb Haemost, 2006 Jul, 96(1): 14-8. Erratum in: Thromb Haemost, 2006 Sep, 96(3): 389.
27. Simcox LE, Ormesher L, Tower C, Greer IA. Throm bophilia and Pregnancy Complications. Int J Mol Sci, 2015 Nov 30, 16(12): 28418-28.
28. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med, 2000 Feb 10, 342(6): 374-80.
29. Bick R.L. Disorders of thrombosis and haemostasis. Clinical and laboratory practice. Third edition. Lippincott Williams and Walkins. 2002. P. 446.
30. Kitchens KS, Alving BM, Kessler CM. Consultative haemostasis and thrombosis. Elsivier Science. 2002. P. 617.
31. Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, Prandoni P, Buller HR, Girolami A, Prins MH. Frequency of pregnancyrelated venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med, 1996 Dec 15, 125(12): 955-60.
32. Ziakas PD, Poulou LS, Pavlou M, Zintzaras E. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk. Eur J Obstet Gynecol Reprod Biol, 2015 Aug, 191: 106-11.
33. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv, 1999 Apr, 54(4): 265-71.
34. Frederiksen J, Juul K, Grande P, Jensen GB, Schroeder TV, Tybjaerg-Hansen A, Nordestgaard BG. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood, 2004 Nov 15, 104(10): 3046-51.
35. Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont’ev SG, Petukhov EB, Kubatiev AA, Savel’ev VS. C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism. Ter Arkh, 2006, 78(6): 70-6.
36. Бицадзе В.О. Принципы диагностики и патогенетической профилактики основных осложнений беременности, обусловленных тромбофилией: Дис. … д-ра мед. наук. М., 2003. 268 с.
37. Sartori MT, Saggiorato G, Spiezia L et al. Influence of the Alu-repeat I/D polymorphism in t-PA gene intron 8 on the stimulated t-PA release after venous occlusion. Clin Appl Thromb Hemost, 2003 Jan, 9(1): 63-9.
38. Oguzulgen IK, Ekim N, Erkekol FO et al. Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population? J Thromb Thrombolysis, 2005 Feb, 19(1): 61-3.
39. Bertina RM, Poort SR, Vos HL, Rosendaal FR. The 46C –>T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis. J Thromb Haemost, 2005 Mar, 3(3): 597-9.
40. Tirado I, Fontcuberta J, Soria JM. Rapid detection of the 46C –> T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes. Genet Test. 2003 Winter;7(4):295-301.
41. Wiklund PG, Nilsson L, Ardnor SN et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke, 2005 Aug, 36(8): 1661-5.
42. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism, 2000 Jul, 49(7): 845-52.
43. Fabbro D, D’Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest, 2003, 56(1): 17-22.
44. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J, Hopmeier P. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem, 2003 Jul, 49(7): 1081-6.
45. Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost, 2003 Jul, 1(7): 1435-42.
46. De Stefano V, Grandone E, Martinelli I. Recommendations for prophylaxis of pregnancyrelated venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines. J Thromb Haemost, 2013 Sep, 11(9): 1779-81.
47. Parilla BV, Fournogerakis R, Archer A, Sulo S, Laurent L, Lee P, Chhotani B, Hesse K, Kulstad E. Diagnosing Pulmonary Embolism in Pregnancy: Are Biomarkers and Clinical Predictive Models Useful? AJP Rep, 2016 Apr, 6(2): e160-4.
48. Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology Am Soc Hematol Educ Program, 2012, 2012: 203-7.
49. James AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med, 2007 Oct, 120(10 Suppl 2): S26-34.
50. Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology, 2002 Aug, 224(2): 487-92.
51. Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, Kaider A. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood, 2002 Aug 1, 100(3): 1060-2.
52. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA. D-dimer levels and risk of recurrent venous thromboembolism. JAMA, 2003 Aug 27, 290(8): 1071-4.
53. Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a metaanalysis of the literature. J Thromb Haemost, 2013 Feb, 11(2): 270-81.
54. Bennett A, Chunilal S. Diagnosis and Management of Deep Vein Thrombosis and Pulmonary Embolism in Pregnancy. Semin Thromb Hemost, 2016 Oct, 42(7): 760-773.
55. Harris T, Meek S. When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature. Emerg Med J, 2005 Nov, 22(11): 766-71.
56. Greer IA. Low-molecular-weight heparin for pregnancy complications. Lancet, 2016 Nov 26, 388(10060): 2570-2572.
57. Gould MK, Dembitzer AD, Doyle RL, et al. Lowmolecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med, 1999, 130: 800–809.
58. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med, 1986, 315(22): 1390-3.
59. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to lowdose aspirin alone. Am J Obstet Gynecol, 1996 May, 174(5): 1584-9.
Рецензия
Для цитирования:
Акиньшина С.В., Бицадзе В.О. ТРОМБОЭМБОЛИЯ ЛЕГОЧНОЙ АРТЕРИИ В АКУШЕРСКОЙ ПРАКТИКЕ. Медицинский Совет. 2017;(13):94-108. https://doi.org/10.21518/2079-701X-2017-13-94-108
For citation:
Akinshina S.V., Bitsadze V.O. PULMONARY ARTERY EMBOLISM IN OBSTETRIC PRACTICES. Meditsinskiy sovet = Medical Council. 2017;(13):94-108. (In Russ.) https://doi.org/10.21518/2079-701X-2017-13-94-108
Просмотров: 497
Послать статью по эл. почте 